RenovaCare products are under development and not approved for sale in the United States.
Results may vary from person to person.
RenovaCare Inc. is a clinical stage biotechnology company focused on developing autologous (self-donated) stem cell therapies for the regeneration of human organs
Our initial products under development target the body’s largest organ, the skin. Our flagship technology, the CellMist™ System, uses our patented SkinGun™ to spray a liquid suspension of a patient’s stem cells - the CellMist™ Solution - onto wounds.
Cell Renewal, Naturally™
ABOUT US
RenovaCare, Inc. is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs.
Contact RenovaCare
